Latest From Biotech Now

Hawaii’s Papaya Industry Takes a Devastating Hit from Hurricane Isselle

Iselle2-115x76

With winds in excess of 60 mph, much of Hawaii experienced significant fallout from Hurricane Isselle.  Most notably, Hawaii’s papaya industry was most impacted by Isselle experiencing shattering commodity losses. The Hawaii Crop Improvement Association (HCIA) preliminary report shows that: The Papaya Industry has sustained damage to 60% of its production and is the most severely impacted crop; Over the next 24+ months the Industry will lose $56 Million dollars;  Total loss and damage to Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , ,

WSJ Editorial: The Medical Innovation Threat

???????????????????????????????

An editorial in today’s Wall Street Journal looks at the rising threat the American insurance industry’s increasingly loud attacks on Sovaldi, a revolutionary new Hepatitis C treatment pose for medical innovation and the development of new specialty drugs. As the editors rightly note, “Sovaldi is the kind of medicine that the drug scolds claim to want—a true scientific advance with a near-perfect cure rate for Hepatitis C, the liver-destroying virus that infects one of every 100 Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Promising vaccine companies set to take the stage at BIO Investor Forum

BIF_logo

It is no secret that vaccines are a hot space in biotech right now, and the 13th Annual BIO Investor Forum will feature several companies working on promising vaccine R&D. The event, scheduled for October 7-8 in San Francisco, Calif., will feature 120 late-stage private and emerging public company presentations. Attendees at the BIO Investor Forum will hear from Immunovaccine, a clinical-stage vaccine development company focused on product candidates for cancer therapy, infectious disease and Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

AP: Groups Claim Insurance Discrimination

scientists115x76

In this August 18 article, Ricardo Alonso-Zaldivar highlights assertions by patient groups that new insurance barriers are discriminatory against sick people, particularly patients with chronic conditions. More than 300 patient advocacy groups – including the AIDS Institute, the American Lung Association, Easter Seals, the Epilepsy Foundation, the Leukemia & Lymphoma Society, the National Alliance on Mental Illness, the National Kidney Foundation and United Cerebral Palsy – recently wrote to Health and Human Services Secretary Sylvia Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Docs to FDA: Biosimilars should have different names than branded drugs

shutterstock_1092009

Yesterday, Fierce Biotech highlighted a letter written by more than 10 medical associations and 20 individual specialists to FDA Commissioner Margaret Hamburg saying that biosimilars “must have distinguishable nonproprietary names. The FDA drafted a set of rules for biosimilars in 2012, sparking a debate on whether those drugs should carry the same generic names as the originator products. Now, some doctors are weighing in on the issue, urging the FDA to require biosimilars to have distinguishable names. The physicians argued that using different Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,